Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD registry TREATgermany (vol 34, pg 1263, 2020)

被引:0
作者
Heratizadeh
机构
关键词
D O I
10.1111/jdv.18838
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:633 / 634
页数:2
相关论文
共 30 条
  • [21] Baseline Characteristics and Treatment Patterns of Patients with Atopic Dermatitis Treated with Oral Systemic Therapies: An Interim Analysis of the AD-REAL Study
    Matthias Augustin
    Esther Serra-Baldrich
    Julien Seneschal
    Susanne Grond
    Anastasia Lampropoulou
    Mohamed Elrayes
    Samuel Ogwu
    Inmaculada de la Torre
    Anthony Bewley
    Andreas Pinter
    Advances in Therapy, 2025, 42 (6) : 2728 - 2738
  • [22] Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)
    Kimball, A. B.
    Leonardi, C.
    Stahle, M.
    Gulliver, W.
    Chevrier, M.
    Fakharzadeh, S.
    Goyal, K.
    Calabro, S.
    Langholff, W.
    Menter, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 137 - 147
  • [23] Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study
    de Bruin-Weller, Marjolein
    Pink, Andrew E.
    Patrizi, Annalisa
    Gimenez-Arnau, Ana M.
    Agner, Tove
    Roquet-Gravy, Pierre-Paul
    Ferrucci, Silvia M.
    Arenberger, Petr
    Svensson, Ake
    Schuttelaar, Marie L. A.
    Nosbaum, Audrey
    Jayawardena, Shyamalie
    Rizova, Elena
    Ardeleanu, Marius
    Eckert, Laurent
    Ozturk, Zafer E.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (02) : 164 - 173
  • [24] Raster-scanning optoacoustic mesoscopy imaging as an objective disease severity tool in atopic dermatitis patients (vol 84, pg 1121, 2021)
    Yew, Y. W.
    Amma, D. Unnimadhava Kurup Soudamini
    Kuan, A. H. Y.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (02) : 536 - 536
  • [25] Improvement in disease severity and quality of life in patients with atopic dermatitis (AD) treated with dupilumab for up to 18 months: Real-world evidence from the PROSE registry
    Bagel, Jerry
    Yosipovitch, Gil
    Pariser, David M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB68 - AB68
  • [26] Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry
    Kavanaugh A.
    Papp K.
    Gottlieb A.B.
    de Jong E.M.G.J.
    Chakravarty S.D.
    Kafka S.
    Langholff W.
    Farahi K.
    Srivastava B.
    Scher J.U.
    BMC Rheumatology, 2 (1)
  • [27] Treatment of moderate to severe atopic dermatitis with dupilumab in real clinical practice. Baseline characteristics of patients from 5 reference dermatology units included in the dupilumab expanded access in Spain
    Juan Pereyra-Rodriguez, Jose
    Alcantara-Luna, Sara
    Ramon Jimenez, Juan
    Carlos Armario-Hita, Jose
    Dominguez-Cruz, Javier
    Martinez-Pilar, Leandro
    Ruiz-Villaverde, Ricardo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB289 - AB289
  • [28] AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History (sept, 10.1007/s40257-023-00819-y, 2023)
    Stingeni, Luca
    Chiricozzi, Andrea
    Calzavara-Pinton, Piergiacomo
    Napolitano, Maddalena
    Peris, Ketty
    Schena, Donatella
    Patruno, Cataldo
    Rossi, Mariateresa
    Foti, Caterina
    Fargnoli, Maria C.
    Corazza, Monica
    Ferrucci, Silvia M.
    Pigatto, Paolo D.
    Romanelli, Marco
    Fabbrocini, Gabriella
    Girolomoni, Giampiero
    Passante, Maria
    Romita, Paolo
    Esposito, Maria
    Schettini, Natale
    Marzano, Angelo V.
    Tonini, Giulia
    Marietti, Rossella
    Casciola, Gabriele
    Argenziano, Giuseppe
    Hansel, Katharina
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (01) : 161 - 161
  • [29] Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis (vol 10, pg 681, 2020)
    Fahrbach, Kyle
    Tarpey, Jialu
    Washington, Evelien Bergrath
    Hughes, Rachel
    Thom, Howard
    Neary, Maureen P.
    Cha, Amy
    Gerber, Robert
    Cappelleri, Joseph C.
    DERMATOLOGY AND THERAPY, 2020, 10 (06) : 1441 - 1444
  • [30] Impact of Baseline Disease Severity on the Long-Term Efficacy and Safety of Abrocitinib Treatment in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of the Long-Term Extension JADE EXTEND Study
    Spergel, Jonathan
    Rice, Zakiya
    Gooderham, Melinda
    Wang, Fang
    Barbarot, Sebastien
    Wollenberg, Andreas
    Biswas, Pinaki
    Chan, Gary
    Alderfer, Justine
    Watkins, Melissa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB190 - AB190